Patients with left ventricular assist devices (LVADs) may benefit from having their pulmonary artery (PA) pressures monitored with the CardioMEMS system (Abbott), a nonrandomized study suggests. In ...
Please provide your email address to receive an email when new articles are posted on . The FDA designated Abbott’s recall of its LVAD communication system as class I, the most serious type. Status of ...
It's been almost a year since St. Jude Medical announced its acquisition of left ventricular assist device (LVAD) maker Thoratec, and the past 12 months have shaken up the LVAD market. Since then, St.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results